Pharmacopeia Drug Discovery, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pharmacopeia Drug Discovery, Inc..The latest application filed is for "cyclic amide bace-1 inhibitors having a benzamide substituent".

Company Profile

0.52.14

Pharmacopeia Drug Discovery, Inc. - Princeton NJ US
Pharmacopeia Drug Discovery, Inc. - La Jolla CA
Pharmacopeia Drug Discovery, Inc. - Cranbury NJ
Pharmacopeia Drug Discovery, Inc. - Cranbry NJ
PHARMACOPEIA DRUG DISCOVERY, INC. - P.O. Box 5350 Princeton NJ
Pharmacopeia Drug Discovery, Inc. - Crambury NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cyclic amide BACE-1 inhibitors having a benzamide substituent Grant 9,062,007 - Cumming , et al. June 23, 2	2015-06-23
Heterocyclic aspartyl protease inhibitors Grant 8,937,093 - Saionz , et al. January 20, 2	2015-01-20
Heterocyclic aspartyl protease inhibitors Grant 8,778,980 - Zhu , et al. July 15, 2	2014-07-15
Substituted isoindolines as aspartyl protease inhibitors Grant 8,722,708 - Stamford , et al. May 13, 2	2014-05-13
Cyclic Amide Bace-1 Inhibitors Having A Benzamide Substituent App 20140128361 - Cumming; Jared N. ; et al.	2014-05-08
Heterocyclic aspartyl protease inhibitors Grant 8,691,831 - Zhu , et al. April 8, 2	2014-04-08
Cyclic amine BACE-1 inhibitors having a benzamide substituent Grant 8,623,867 - Cumming , et al. January 7, 2	2014-01-07
Heterocyclic aspartyl protease inhibitors Grant 8,242,112 - Zhu , et al. August 14, 2	2012-08-14
Heterocyclic substituted piperazines with CXCR3 antagonist activity Grant 8,207,170 - Kim , et al. June 26, 2	2012-06-26
Heterocyclic aspartyl protease inhibitors Grant 8,178,513 - Zhu , et al. May 15, 2	2012-05-15
ALPHA2C adrenoreceptor agonists Grant 7,985,748 - McCormick , et al. July 26, 2	2011-07-26
Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity Grant 7,879,838 - Zeng , et al. February 1, 2	2011-02-01
Heterocyclic substituted piperazines with CXCR3 antagonist activity Grant 7,868,006 - Kim , et al. January 11, 2	2011-01-11
Heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity Grant 7,799,789 - Anilkumar , et al. September 21, 2	2010-09-21
Thiadiazoles as CXC- and CC- chemokine receptor ligands Grant 7,786,149 - Biju , et al. August 31, 2	2010-08-31
Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith Grant 7,723,340 - Albers , et al. May 25, 2	2010-05-25
Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity Grant 7,566,718 - Wong , et al. July 28, 2	2009-07-28
Purinone derivatives for treating neurodegenerative diseases App 20090023723 - Cole; Andrew G. ; et al.	2009-01-22
Substituted 2-aminothiazoles for treating neurodegenerative diseases App 20090005568 - Cole; Andrew G. ; et al.	2009-01-01
Substituted [1,4]-diazepanes as CXCR3 antagonists and their use in the treatment of inflammatory disorders App 20080312215 - Cole; Andrew G. ; et al.	2008-12-18
7-Substituted Purine Derivatives for Immunosuppression App 20080119496 - Ohlmeyer; Michael J. ; et al.	2008-05-22
Purinones and 1H-imidazopyridinones as PKC-theta inhibitors App 20080085909 - Roughton; Andrew ; et al.	2008-04-10
8-heteroarylpurine Mnk2 Inhibitors For Treating Metabolic Disorders App 20080032971 - Cole; Andrew G. ; et al.	2008-02-07
Methods and apparatus for improved fluid control utilizing a U-valve employing a bidirectional check valve Grant 7,309,470 - Feygin December 18, 2	2007-12-18
Aminopurine Derivatives For Treating Neurodegenerative Diseases App 20070225304 - Cole; Andrew G. ; et al.	2007-09-27
Methods for measuring phosphatase activity Grant 7,202,050 - Auld April 10, 2	2007-04-10
VLA-4 inhibitor compounds Grant 7,179,819 - Baldwin , et al. February 20, 2	2007-02-20
Azinone and diazinone V3 inhibitors for depression and stress disorders App 20070037822 - Letourneau; Jeffrey John ; et al.	2007-02-15
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,161,003 - Guzi , et al. January 9, 2	2007-01-09
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands Grant 7,132,445 - Taveras , et al. November 7, 2	2006-11-07
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,119,200 - Guzi , et al. October 10, 2	2006-10-10
One-dimensional QSAR models App 20060206269 - Diller; David John ; et al.	2006-09-14
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,084,271 - Guzi , et al. August 1, 2	2006-08-01
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,078,525 - Guzi , et al. July 18, 2	2006-07-18
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,074,924 - Guzi , et al. July 11, 2	2006-07-11
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,067,661 - Guzi , et al. June 27, 2	2006-06-27
Orthologues of human receptors and methods of use Grant 7,041,463 - Horlick , et al. May 9, 2	2006-05-09
Diazabicyclononane scaffold for combinatorial synthesis Grant 7,038,054 - Baldwin , et al. May 2, 2	2006-05-02
Pyrimidine derivatives as IL-8 receptor antagonists Grant 7,037,916 - Erickson , et al. May 2, 2	2006-05-02
Aryl and biaryl compounds having MCH modulatory activity Grant 7,034,056 - Hobbs , et al. April 25, 2	2006-04-25
Pyrimidine kinase inhibitors App 20050277642 - Erickson, Shawn David ; et al.	2005-12-15
Methods for measuring kinase activity Grant 6,942,987 - Auld September 13, 2	2005-09-13
Methods for measuring phosphatase activity App 20050191718 - Auld, Douglas	2005-09-01
Bradykinin B1 receptor antagonists Grant 6,919,347 - Ohlmeyer , et al. July 19, 2	2005-07-19
3,4-di-substituted maleimide compounds as CXC chemokine receptor antagonists Grant 6,903,131 - Taveras , et al. June 7, 2	2005-06-07
Bisaryl derivatives having FSH modulatory activity Grant 6,900,213 - Guo , et al. May 31, 2	2005-05-31
Method and apparatus for universal fluid exchange Grant 6,890,491 - Feygin , et al. May 10, 2	2005-05-10
N-heterocyclic derivatives as NOS inhibitors Grant 6,887,865 - Arnaiz , et al. May 3, 2	2005-05-03
Aryl and biaryl piperdines with MCH modulatory activity Grant 6,887,889 - Hobbs , et al. May 3, 2	2005-05-03
3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists Grant 6,878,709 - Taveras , et al. April 12, 2	2005-04-12
Methods and apparatus for improved fluid control utilizing a U-valve employing a bidirectional check valve App 20050059164 - Feygin, Ilya	2005-03-17
N-heterocyclic derivatives as NOS inhibitors Grant 6,864,263 - Arnaiz , et al. March 8, 2	2005-03-08
N-heterocyclic derivatives as NOS inhibitors Grant 6,864,368 - Arnaiz , et al. March 8, 2	2005-03-08
N-heterocyclic derivatives as NOS inhibitors Grant 6,849,739 - Arnaiz , et al. February 1, 2	2005-02-01
Piperidine compounds Grant 6,849,621 - Rosenblum , et al. February 1, 2	2005-02-01
Methods and apparatus for improved fluid control utilizing a U-valve employing a flow-interruption device Grant 6,846,461 - Feygin January 25, 2	2005-01-25
N-heterocyclic derivatives as NOS inhibitors Grant 6,846,829 - Arnaiz , et al. January 25, 2	2005-01-25
N-heterocyclic derivatives as NOS inhibitors Grant 6,841,674 - Arnaiz , et al. January 11, 2	2005-01-11
Fluorescent capture assay for kinase activity employing an anti-phosphotyrosine antibody as both the capture agent and detecting agent Grant 6,806,056 - Glickman , et al. October 19, 2	2004-10-19
Combinatorial dihydrobenzopyran library Grant 6,790,965 - Baldwin , et al. September 14, 2	2004-09-14
VLA-4 inhibitor compounds Grant 6,756,378 - Baldwin , et al. June 29, 2	2004-06-29
Single channel reformatter Grant 6,694,197 - Hatcher , et al. February 17, 2	2004-02-17
Photocleavable and acid cleavable linkers for combinatorial chemistry Grant 6,642,417 - Tran , et al. November 4, 2	2003-11-04
Methods and apparatus for high throughput plate to plate or plate to membrane transfer Grant 6,627,447 - Burbaum , et al. September 30, 2	2003-09-30

Company Registrations

NCAGE Code	34CF5	PHARMACOPEIA DRUG DISCOVERY INC.
CAGE Code	34CF5	PHARMACOPEIA DRUG DISCOVERY, INC.
DUNS	141608112	PHARMACOPEIA DRUG DISCOVERY, INC.